{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:45:58Z","timestamp":1784241958048,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T00:00:00Z","timestamp":1375488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00508-013-0408-1","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T08:43:58Z","timestamp":1375433038000},"page":"537-540","source":"Crossref","is-referenced-by-count":4,"title":["Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature","PEG Interferon alpha assoziierte Psoriasis bei einem Patienten mit akuter Hepatitis Cund \u00dcbersicht \u00fcber die entsprechende Literatur"],"prefix":"10.1007","volume":"125","author":[{"given":"Muhammed Sait","family":"Dag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynel Abidin","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimet","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"\u00c7am","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Kaday\u0131f\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,3]]},"reference":[{"issue":"3","key":"408_CR1","first-page":"249","volume":"15","author":"FA Caruntu","year":"2006","unstructured":"Caruntu FA, Benea L. Acute hepatitis C virus infection: Diagnosis, pathogenesis, treatment. J Gastrointestin Liver Dis. 2006;15(3):249\u201356.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"408_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.gastro.2005.11.010","volume":"130","author":"JL Dienstag","year":"2006","unstructured":"Dienstag JL, McHutchison JG. American Gastroenterological Association. Technical review on the management of hepatitis C. Gastroenterology. 2006;130(1):231\u201364.","journal-title":"Gastroenterology"},{"issue":"10","key":"408_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1155\/2009\/651952","volume":"23","author":"N Mistry","year":"2009","unstructured":"Mistry N, Shapero J, Crawford RI. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can J Gastroenterol. 2009;23(10):677\u201383.","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"408_CR4","first-page":"20","volume":"52","author":"VH Chong","year":"2011","unstructured":"Chong VH. Autoimmune thyroiditis and delayed onset psoriasis in association with combination therapy for chronic hepatitis C infection. Singapore Med J. 2011;52(2):20\u20132.","journal-title":"Singapore Med J"},{"issue":"4","key":"408_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1440-0960.2011.00767.x","volume":"53","author":"MC Wu","year":"2012","unstructured":"Wu MC, Lee JY. Generalized flare of pustular psoriasis induced by PEGylated interferon-\u03b12b therapy for chronic hepatitis C. Australas J Dermatol. 2012;53(4):69\u201372.","journal-title":"Australas J Dermatol"},{"issue":"9","key":"408_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/MEG.0b013e32816e070b","volume":"19","author":"A Yurci","year":"2007","unstructured":"Yurci A, Guven K, Torun E, et al. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. Eur J Gastroenterol Hepatol. 2007;19(9):811\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"408_CR7","first-page":"319","volume":"12","author":"M Traub","year":"2007","unstructured":"Traub M, Marshall K. Psoriasis-pathophysiology, conventional, and alternative approaches to treatment. Altern Med Rev. 2007;12(4):319\u201330.","journal-title":"Altern Med Rev"},{"issue":"1","key":"408_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11894-001-0038-z","volume":"3","author":"ML Shiffman","year":"2001","unstructured":"Shiffman ML. Pegylated interferons: what role will they play in the treatment of chronic hepatitis C? Curr Gastroenterol Rep. 2001;3(1):30\u20137.","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"408_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1742-1241.2006.01040.x","volume":"64","author":"NS Tekin","year":"2010","unstructured":"Tekin NS, Ustundag Y, Tekin IO, Koca R, Altinyazar HC. Early administration of ultraviolet treatment is effective in pegylated interferon alpha-induced severe acute exacerbation of psoriasis: a case report and short review of the literature. Int J Clin Pract. 2010;64(1):101\u20133.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"408_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2230.2000.00655-4.x","volume":"25","author":"AM Downs","year":"2000","unstructured":"Downs AM, Dunnill MG. Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C. Clin Exp Dermatol. 2000;25(4):351\u20132.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"408_CR11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","volume":"125","author":"J Funk","year":"1991","unstructured":"Funk J, Langeland T, Schrumpf E, Hanssen LE. Psoriasis induced by interferon-a. Br J Dermatol. 1991;125(5):463\u20135.","journal-title":"Br J Dermatol"},{"issue":"2","key":"408_CR12","first-page":"107","volume":"15","author":"I Ketikoglou","year":"2005","unstructured":"Ketikoglou I, Karatapanis S, Elefsiniotis I, Kafiri G, Moulakakis A. Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. Eur J Dermatol. 2005;15(2):107\u20139.","journal-title":"Eur J Dermatol"},{"issue":"12","key":"408_CR13","first-page":"760","volume":"11","author":"A Horev","year":"2009","unstructured":"Horev A, Halevy S. New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C. Isr Med Assoc J. 2009;11(12):760\u20131.","journal-title":"Isr Med Assoc J"},{"issue":"7","key":"408_CR14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/ard.2010.139824","volume":"70","author":"I Mederacke","year":"2011","unstructured":"Mederacke I, Witte T, Wedemeyer H, Meyer-Olson D. Successful clearance of hepatitis C virus with pegylated interferon \u03b1-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis. Ann Rheum Dis. 2011;70(7):1343\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"408_CR15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00365548.2012.720026","volume":"45","author":"F Bartalesi","year":"2013","unstructured":"Bartalesi F, Salomoni E, Cavallo A, Corti G, Pimpinelli N, Bartoloni A, et al. Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents? Scand J Infect Dis. 2013;45(4):320\u20133.","journal-title":"Scand J Infect Dis"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0408-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-013-0408-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0408-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:53:34Z","timestamp":1559094814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-013-0408-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,3]]},"references-count":15,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s00508-013-0408-1","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,3]]}}}